These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 39057947)

  • 1. Shining a Light on Venom-Peptide Receptors: Venom Peptides as Targeted Agents for In Vivo Molecular Imaging.
    Chow CY; King GF
    Toxins (Basel); 2024 Jul; 16(7):. PubMed ID: 39057947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptides for in vivo target-specific cancer imaging.
    Ferro-Flores G; Ramírez Fde M; Meléndez-Alafort L; Santos-Cuevas CL
    Mini Rev Med Chem; 2010 Jan; 10(1):87-97. PubMed ID: 20380643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulation Studies and Dynamic Interaction of Venom Peptides with Ion Channels.
    Khan N; Niazi ZR; Khan NR; Shah K; Rehman K; Wahab A; Khan S
    Protein Pept Lett; 2018; 25(7):652-662. PubMed ID: 29921195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseases.
    Cardoso FC
    Biochem Pharmacol; 2020 Nov; 181():114107. PubMed ID: 32579958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Dysregulated Ion Channels in Liver Tumors with Venom Peptides.
    Achimba F; Faezov B; Cohen B; Dunbrack R; Holford M
    Mol Cancer Ther; 2024 Feb; 23(2):139-147. PubMed ID: 38015557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venom-derived peptides inhibiting Kir channels: Past, present, and future.
    Doupnik CA
    Neuropharmacology; 2017 Dec; 127():161-172. PubMed ID: 28716449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Simulations of Disulfide-Rich Venom Peptides with Ion Channels and Membranes.
    Deplazes E
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine-Based Selection of Drugs That Target Ion Channels from Combinatorial Venom Peptide Libraries.
    Zhang H; Du M; Xie J; Liu X; Sun J; Wang W; Xin X; Possani LD; Yea K; Lerner RA
    Angew Chem Int Ed Engl; 2016 Aug; 55(32):9306-10. PubMed ID: 27197631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venom-derived peptide inhibitors of voltage-gated potassium channels.
    Norton RS; Chandy KG
    Neuropharmacology; 2017 Dec; 127():124-138. PubMed ID: 28689025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venom peptides as therapeutics: advances, challenges and the future of venom-peptide discovery.
    Robinson SD; Undheim EAB; Ueberheide B; King GF
    Expert Rev Proteomics; 2017 Oct; 14(10):931-939. PubMed ID: 28879805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of venom peptides to probe ion channel structure and function.
    Dutertre S; Lewis RJ
    J Biol Chem; 2010 Apr; 285(18):13315-20. PubMed ID: 20189991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal peptides targeting voltage-activated sodium channels.
    Billen B; Bosmans F; Tytgat J
    Curr Pharm Des; 2008; 14(24):2492-502. PubMed ID: 18781997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Studies of Venom Peptides Targeting Potassium Channels.
    Chen R; Chung SH
    Toxins (Basel); 2015 Dec; 7(12):5194-211. PubMed ID: 26633507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venom-derived modulators of epilepsy-related ion channels.
    Chow CY; Absalom N; Biggs K; King GF; Ma L
    Biochem Pharmacol; 2020 Nov; 181():114043. PubMed ID: 32445870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakthroughs in Venom Peptide Screening Methods to Advance Future Drug Discovery.
    Napolitano T; Holford M
    Protein Pept Lett; 2018; 25(12):1137-1148. PubMed ID: 30381057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological screening technologies for venom peptide discovery.
    Prashanth JR; Hasaballah N; Vetter I
    Neuropharmacology; 2017 Dec; 127():4-19. PubMed ID: 28377116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venoms as a platform for human drugs: translating toxins into therapeutics.
    King GF
    Expert Opin Biol Ther; 2011 Nov; 11(11):1469-84. PubMed ID: 21939428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in animal venom peptide nanotherapeutics with improved selectivity for cancer cells.
    Giribaldi J; Smith JJ; Schroeder CI
    Biotechnol Adv; 2021; 50():107769. PubMed ID: 33989705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in venom peptide drug discovery: where are we at and where are we heading?
    Smallwood TB; Clark RJ
    Expert Opin Drug Discov; 2021 Oct; 16(10):1163-1173. PubMed ID: 33914674
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid sensitive analysis of cysteine rich peptide venom components.
    Ueberheide BM; Fenyö D; Alewood PF; Chait BT
    Proc Natl Acad Sci U S A; 2009 Apr; 106(17):6910-5. PubMed ID: 19380747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.